返回 Agenda
Electronic Labeling: Where are we Now and What are the Next Steps in the World?
Session Chair(s)
Rie Matsui, RPH
Senior Director, Regional Labeling Head for APAC
Pfizer R&D Japan G.K., Japan
The most updated eLabeling initiatives in the US, EU, Canada, and Japan, and the trends for eLabeling in emerging markets will be shared. The possibility of the convergence of the eLabeling initiatives will be discussed in the digital health.v
Learning Objective : Describe the most updated electronic labeling initiatives in the US, EU, Canada, Japan, and emerging countries; Discuss the possibility of the convergence for electronic labeling across regions.
Speaker(s)
eLabeling Updates in Japan and Collaboration with Asia Countries
Shinobu Uzu, PHD
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Senior Executive Director
Electronic Product Information (ePI) in the EU: Progress and the Road Ahead
Elizabeth Scanlan, PHD, MSC
European Medicines Agency, Netherlands
ePI Product Owner
Behind the Scenes in Implementing eLabeling: COVID-19 Vaccine Label Development During a Global Pandemic
Christine Wood, PHD
AstraZeneca, United Kingdom
Global Labeling TA Director (Respiratory and Immunology)